ClinVar Miner

Submissions for variant NM_006005.3(WFS1):c.1265C>T (p.Ala422Val)

gnomAD frequency: 0.00029  dbSNP: rs150368988
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Personalized Diabetes Medicine Program, University of Maryland School of Medicine RCV000445460 SCV000537009 uncertain significance Monogenic diabetes 2016-03-04 criteria provided, single submitter research ACMG Criteria: PP3, BP4
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000825498 SCV000966801 uncertain significance not specified 2018-11-13 criteria provided, single submitter clinical testing The p.Ala422Val variant in WFS1 has not been previously reported in individuals with hearing loss or Wolfram syndrome, but has been identified in 0.035% (45/129 150) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 393388). Computational p rediction tools and conservation analysis do not provide strong support for or a gainst an impact to the protein. In summary, the clinical significance of the p. Ala422Val variant is uncertain. ACMG/AMP Criteria applied: None.
Athena Diagnostics RCV000993556 SCV001146646 uncertain significance not provided 2019-04-19 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001157339 SCV001318901 uncertain significance Autosomal dominant nonsyndromic hearing loss 6 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Illumina Laboratory Services, Illumina RCV001157340 SCV001318902 uncertain significance WFS1-Related Spectrum Disorders 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
GeneDx RCV000993556 SCV001805362 uncertain significance not provided 2023-05-04 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function
Genetic Services Laboratory, University of Chicago RCV000825498 SCV002064895 uncertain significance not specified 2021-12-20 criteria provided, single submitter clinical testing DNA sequence analysis of the WFS1 gene demonstrated a sequence change, c.1265C>T, in exon 8 that results in an amino acid change, p.Ala422Val. This sequence change has been described in the gnomAD database with a frequency of 0.03% in the non-Finnish European subpopulation (dbSNP rs150368988). The p.Ala422Val change affects a moderately conserved amino acid residue located in a domain of the WFS1 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Ala422Val substitution. This sequence change does not appear to have been previously described in individuals with WFS1-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Ala422Val change remains unknown at this time.
Labcorp Genetics (formerly Invitae), Labcorp RCV000993556 SCV002432223 likely benign not provided 2023-12-11 criteria provided, single submitter clinical testing
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic RCV002509384 SCV002817344 uncertain significance Wolfram syndrome 1 criteria provided, single submitter research Potent mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy.However no sufficient evidence is found to ascertain the role of this particular variant rs150368988 in Wolfram's syndrome yet.
Revvity Omics, Revvity RCV000993556 SCV003823771 uncertain significance not provided 2022-04-07 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.